Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/10/2018 |
| Start Date: | April 2015 |
| End Date: | October 2031 |
Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct
Long term safety follow-up of Cal-1 recipients
Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T
Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46
(Cal-1), a Dual Anti-HIV Gene Transfer Construct
Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46
(Cal-1), a Dual Anti-HIV Gene Transfer Construct
Inclusion Criteria:
- Signed informed consent
- Previous treatment with the Cal-1 modified hematopoietic cellular products
Exclusion Criteria:
- Inability to understand and provide informed consent
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials